Poultry Pharmaceuticals Market, By Product Type (Drugs (VETRIMOXIN, Other Drug Products), Vaccines (INNOVAX, NOBILIS, Poulvac, Other Vaccine Products), and Feed Additives (VIGOSINE, Amnovit, Other Feed Additives)), By Animal Type (Chicken, Turkey, Duck, Goose, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023

Code : CMI3879

Pages :180

Formats :

Excel and PDF

Industry : Pharmaceutical

Market News

Global Poultry Pharmaceuticals Market: Key Developments

In February 2021, Merck Animal Health is parent company of MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., is an American multinational pharmaceutical company announced the completion of its acquisition of PrognostiX Poultry Limited d/b/a Poultry Sense Ltd. from its founding shareholders. Poultry Sense Ltd. is an innovator in health and environmental monitoring solutions for the poultry industry.

In April 2022, Ceva Animal Health, is the animal health company in France, launched CEVAC IBird, a live attenuated freeze-dried vaccine, for the active immunization of chickens against the variant strain of avian infectious bronchitis virus, containing strain 1/96, in India.

In August 2022, Bimeda, Inc., a veterinary pharmaceutical and animal health specialist company in Kenya, announced its latest significant investment, via the acquisition of South Africa's leading animal health distributor, Afrivet Southern Africa Proprietary Limited. the acquisition provide Bimeda with the largest footprint of any animal health company on the African continent.

In October 2020, Boehringer Ingelheim Animal Health, a pharmaceutical company in Mumbai, launched an innovative, first-of-its-kind vaccine in the U.S. to protect poultry from three diseases. VAXXITEK HVT+IBD+ILT is the first vaccine to offer protection in one shot from Infectious Laryngotracheitis, Marek's Disease and Infectious Bursal Disease (classic and variant types).

On February 14, 2023, Boehringer Ingelheim Animal Health USA Inc., announced they have entered a strategic collaboration with Alizent, a subsidiary of Air Liquide, to implement an innovative cold chain tracking solution to enhance poultry vaccine supply chain management. Some poultry vaccines are frozen at -200°C (-328°F) and shipped in containers, known as Dewars, filled with liquid nitrogen (LN2) to maintain the cold temperature during transit and protect the efficacy of live cells inside the vaccines. The collaboration taps into the growing interconnectivity of the Internet of Things (IoT) by using Alizent’s SmartDewar IoT platform to track Dewars housing liquid nitrogen and cryogenic samples, such as poultry vaccines.